⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14255178 | 0.87 | — | — | |
| SCHEMBL14255107 | 0.77 | — | — | |
| SCHEMBL14255057 | 0.77 | — | — | |
| SCHEMBL15099814 | 0.75 | — | — | |
| SCHEMBL1867102 | 0.75 | — | — | |
| SCHEMBL12954869 | 0.75 | — | — | |
| SCHEMBL17683699 | 0.73 | — | — | |
| SCHEMBL17683671 | 0.72 | — | — | |
| SCHEMBL14309040 | 0.72 | — | — | |
| SCHEMBL13673246 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023214576-A1 | CYCLIC COMPOUND HAVING SELECTIVE KRAS INHIBITORY EFFECT ON HRAS AND NRAS | 中外製薬株式会社 | 2023-11-09 | — | — | WO | disclosed |
| US-20230340328-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-26 | — | — | US | disclosed |
| US-20160060528-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2016-03-03 | — | — | US | disclosed |
| US-9249355-B2 | Liquid-crystal displays having homeotropic alignment | MERCK PATENT GMBH (DE) | 2016-02-02 | — | — | US | disclosed |
| US-9234135-B2 | Liquid-crystalline medium and liquid-crystal displays | MERCK PATENT GMBH (DE) | 2016-01-12 | — | — | US | disclosed |
| US-20150301368-A1 | Liquid-crystal displays and liquid-crystalline media having homeotropic alignment | MERCK PATENT GMBH (DE) | 2015-10-22 | — | — | US | disclosed |
| US-20150252265-A1 | LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2015-09-10 | — | — | US | disclosed |
| US-20150048276-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2015-02-19 | — | — | US | disclosed |
| US-8956550-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2015-02-17 | — | — | US | disclosed |
| US-8906261-B2 | Liquid crystal medium containing thiophene derivatives | MERCK PATENT GMBH (DE) | 2014-12-09 | — | — | US | disclosed |
| EP-1341871-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-10-29 | — | — | EP | disclosed |
| EP-1403356-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2008-09-17 | — | — | EP | disclosed |
| EP-1658352-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-04-02 | — | — | EP | disclosed |
| EP-1690915-B1 | Mesogenic compounds, liquid crystal medium and liquid crystal display | MERCK PATENT GMBH (DE) | 2008-03-26 | — | — | EP | disclosed |
| EP-1690916-B1 | Mesogenic compounds, liquid crystal medium and liquid crystal display | MERCK PATENT GMBH (DE) | 2008-03-12 | — | — | EP | disclosed |
| WO-2008009398-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2008-01-24 | — | — | WO | disclosed |
| WO-2007147516-A1 | MESOGENIC COMPOUNDS, LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2007-12-27 | — | — | WO | disclosed |
| EP-1816180-A1 | Mesogenic compounds, liquid crystal medium, and liquid crystal display | Merck Patent GmbH (DE) | 2007-08-08 | — | — | EP | disclosed |
| EP-1551937-B1 | PHOTOSTABLE LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2007-07-11 | — | — | EP | disclosed |
| EP-1739151-A1 | Mesogenic compounds, liquid crystal medium and liquid display | MERCK PATENT GmbH (DE) | 2007-01-03 | — | — | EP | disclosed |